BR112017005759A2 - composição de preparação externa que contém s-flurbiprofeno - Google Patents

composição de preparação externa que contém s-flurbiprofeno

Info

Publication number
BR112017005759A2
BR112017005759A2 BR112017005759A BR112017005759A BR112017005759A2 BR 112017005759 A2 BR112017005759 A2 BR 112017005759A2 BR 112017005759 A BR112017005759 A BR 112017005759A BR 112017005759 A BR112017005759 A BR 112017005759A BR 112017005759 A2 BR112017005759 A2 BR 112017005759A2
Authority
BR
Brazil
Prior art keywords
flurbiprofen
composition containing
external preparation
preparation composition
mid
Prior art date
Application number
BR112017005759A
Other languages
English (en)
Inventor
MATSUKI Kota
Sato Takayuki
UCHIKAWA Yasumasa
Original Assignee
Taisho Pharmaceutical Co Ltd
Tokuhon Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd, Tokuhon Corp filed Critical Taisho Pharmaceutical Co Ltd
Publication of BR112017005759A2 publication Critical patent/BR112017005759A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Cosmetics (AREA)

Abstract

a presente invenção refere-se a uma composição para aplicação externa contendo s-flurbiprofeno e óleo de menta como um potenciador de penetração da pele, no qual é suprimida uma diminuição dependente do tempo do conteúdo de s-flurbiprofeno para melhorar a estabilidade de armazenamento do s-flurbiprofeno. para atingir este objetivo, pelo menos um membro selecionado a partir do grupo que consiste em um éster tendo dois ácidos graxos de cadeia média ligados a propilenoglicol e um éster tendo três ácidos graxos de cadeia média ligados a glicerina é incorporado em uma composição para aplicação externa contendo s-flurbiprofeno e óleo de menta como um potenciador de penetração da pele.
BR112017005759A 2014-10-07 2015-09-15 composição de preparação externa que contém s-flurbiprofeno BR112017005759A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014206781 2014-10-07
PCT/JP2015/076109 WO2016056356A1 (ja) 2014-10-07 2015-09-15 Ｓ－フルルビプロフェンを含有する外用剤組成物

Publications (1)

Publication Number Publication Date
BR112017005759A2 true BR112017005759A2 (pt) 2017-12-12

Family

ID=55652977

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017005759A BR112017005759A2 (pt) 2014-10-07 2015-09-15 composição de preparação externa que contém s-flurbiprofeno

Country Status (14)

Country Link
EP (1) EP3205341A4 (pt)
JP (2) JP6023358B2 (pt)
KR (1) KR20170063700A (pt)
CN (1) CN107148269B (pt)
AU (1) AU2015329319B2 (pt)
BR (1) BR112017005759A2 (pt)
CA (1) CA2962034A1 (pt)
MX (1) MX371533B (pt)
MY (1) MY187120A (pt)
PH (1) PH12017500528B1 (pt)
RU (1) RU2715907C2 (pt)
SG (1) SG11201702334SA (pt)
TW (1) TWI717323B (pt)
WO (1) WO2016056356A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI803469B (zh) * 2016-10-12 2023-06-01 日商帝國製藥股份有限公司 水性貼附劑
JP6877737B2 (ja) * 2017-03-31 2021-05-26 三笠製薬株式会社 フルルビプロフェン含有含水系貼付剤
WO2020032271A1 (ja) 2018-08-10 2020-02-13 国立大学法人東北大学 多価アルコールエステル化合物の製造方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5829706A (ja) * 1981-08-14 1983-02-22 Toko Yakuhin Kogyo Kk 消炎鎮痛外用剤
JPH06199701A (ja) * 1992-12-29 1994-07-19 Lion Corp 外用消炎鎮痛剤
JP3402682B2 (ja) * 1993-09-08 2003-05-06 サンスター株式会社 歯磨組成物
JP3782834B2 (ja) * 1994-10-26 2006-06-07 株式会社トクホン 鎮痛抗炎症貼付剤
JP2002225883A (ja) * 2001-02-01 2002-08-14 Saitama Daiichi Seiyaku Kk 貼付剤用包装袋
JP4818575B2 (ja) * 2003-06-30 2011-11-16 ライオン株式会社 外用貼付剤及び放射線照射外用貼付剤の変色防止方法
MXPA06001776A (es) * 2003-08-15 2007-09-07 Qlt Usa Inc Sistema de suministro de farmaco transmucosal biocorrosivo, adhesivo.
US7442399B2 (en) * 2004-06-25 2008-10-28 Kraft Foods Holdings, Inc. Aroma-producing compositions for foods
JP4762565B2 (ja) * 2005-02-08 2011-08-31 久光製薬株式会社 包装袋
JP2009204389A (ja) * 2008-02-27 2009-09-10 Toppan Printing Co Ltd 離型フィルムおよび薬品移行性の評価方法
JPWO2010103845A1 (ja) * 2009-03-11 2012-09-13 興和株式会社 鎮痛・抗炎症剤含有外用剤
CN102341123A (zh) * 2009-03-11 2012-02-01 兴和株式会社 含有镇痛-抗炎症剂的外用剂
WO2010103844A1 (ja) * 2009-03-11 2010-09-16 興和株式会社 鎮痛・抗炎症剤含有外用剤
GB201010954D0 (en) * 2010-06-29 2010-08-11 Edko Pazarlama Tanitim Ticaret Compositions
JP2012219055A (ja) * 2011-04-07 2012-11-12 Nitto Denko Corp 貼付製剤およびその包装体
JP2013066644A (ja) * 2011-09-26 2013-04-18 Toppan Printing Co Ltd 消炎鎮痛成分低吸着包材
GB201216893D0 (en) * 2012-09-21 2012-11-07 Aesica Pharmaceuticals Ltd Drug substance preparations, pharmaceutical compositions and dosage forms comprising s-(+)-flurbiprofen

Also Published As

Publication number Publication date
PH12017500528A1 (en) 2017-08-07
EP3205341A4 (en) 2018-05-30
KR20170063700A (ko) 2017-06-08
JP6683443B2 (ja) 2020-04-22
EP3205341A1 (en) 2017-08-16
CN107148269B (zh) 2020-03-31
JP2016073623A (ja) 2016-05-12
CA2962034A1 (en) 2016-04-14
RU2715907C2 (ru) 2020-03-04
AU2015329319B2 (en) 2018-12-13
AU2015329319A1 (en) 2017-04-20
SG11201702334SA (en) 2017-05-30
TW201625228A (zh) 2016-07-16
MX371533B (es) 2020-01-30
PH12017500528B1 (en) 2017-08-07
JP6023358B2 (ja) 2016-11-09
RU2017115933A3 (pt) 2019-03-06
CN107148269A (zh) 2017-09-08
MY187120A (en) 2021-09-02
RU2017115933A (ru) 2018-11-13
WO2016056356A1 (ja) 2016-04-14
JPWO2016056356A1 (ja) 2017-04-27
TWI717323B (zh) 2021-02-01
MX2017004505A (es) 2017-06-26

Similar Documents

Publication Publication Date Title
BR112017002221A2 (pt) 2-(morfolin-4-il)-1,7-naftiridinas
BR112016030835B8 (pt) Composição para crescimento de cabelos contendo minoxidil
CR20160229A (es) Inhibidires de bromodominio
CU24410B1 (es) Benzimidazol-2-aminas como inhibidores de midh1
EA201890086A1 (ru) 1,4-замещенные производные пиперидина
BR112018005194A2 (pt) processo de composto antifúngico
CL2017001046A1 (es) Inhibidoes del bromodominio
BR112016021648A2 (pt) novos compostos
BR112017022209A2 (pt) composição aquosa que compreende éster de ácido omega- aminocarboxílico e álcool graxo e seu uso
MX2016006094A (es) Eliminacion de componentes de propanol indeseables.
BR112017013445A2 (pt) processo para aumentar a estabilidade de uma composição que compreende ácidos graxos ômega 6 poli-insaturados
BR112015021813A2 (pt) éster de isononila na base de misturas de ácidos graxos de óleos vegetais
BR112017005821A2 (pt) formulação aquosa, método para a preparação de uma formulação aquosa, conjunto, método para a preparação de uma composição farmacêutica, composição farmacêutica e método para quimicamente estabilizar uma formulação aquosa
DOP2016000120A (es) Nuevos inhibidores de dgat2
BR112017008033A2 (pt) composição farmacêutica para administração oral e respectivo processo de preparação
BR112015005364A8 (pt) uso de composições de gordura para manter uma palatabilidade intensificada de alimento para animal de estimação ao longo do tempo, método para preparar a referida composição e kit contendo a referida composição
BR112017006425A2 (pt) derivado de isoxazol como inibidor de isocitrato desidrogenase 1 mutante
BR112017011476A2 (pt) composição baseada em aminoácidos para recuperação de fibroelastina em tecidos conjuntivos dérmicos e uso
CO2019012475A2 (es) Composiciones y productos de fragancia novedosos con efectos mejoradores del estado de ánimo
BR112017005759A2 (pt) composição de preparação externa que contém s-flurbiprofeno
BR112017023144A2 (pt) composições cosméticas compreendendo ésteres de estolídeo e usos para o tratamento capilar
BR112012030643A2 (pt) líquido da casca da castanha de caju tendo estabilidade melhorada
BR112017019059A2 (pt) composição de aditivo para composição de borracha composta de sílica, composição de borracha e pneu
BR112016013992A2 (pt) Composição cosmética
BR112016021656A2 (pt) inibidores das vias de sinalização de wnt

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2688 DE 12-07-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.